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Abstract 
Schistosomes are easily transmitted and high chance of repeat infection, so if control strategies based on 
targeted mass drug administration (MDA) are to succeed it is essential to have a test that is sensitive, accurate 
and simple to use. It is known and regularly demonstrated that praziquantel does not always eliminate an 
infection so in spite of the successes of control programs a residual of the reservoir survives to re-infect snails. 
The issue of diagnostic sensitivity becomes more critical in the assessment of program effectiveness. 
While serology, such as antigen capture tests might improve sensitivity, it has been shown that the presence of 
species-specific DNA fragments will indicate, most effectively, the presence of active parasites. Polymerase chain 
reaction (PCR) can amplify and detect DNA from urine residuecaptured on Whatman No. 3 filter paper that is 
dried after filtration. Previously we have detected S. mansoni and S. haematobium parasite-specific small repeat 
DNA fragment from filtered urine on filter paper by PCR. In the current study, we assessed the efficacy of 
detection of 86 urine samples for either or both schistosome parasites by PCR and loop-mediated isothermal 
amplification (LAMP) that were collected from a low to moderate transmission area in Ghana. Two 
different DNA extraction methods, standard extraction kit and field usable LAMP-PURE kit were also evaluated 
by PCR and LAMP amplification. With S. haematobium LAMP amplification for both extractions showed similar 
sensitivity and specificity when compared with PCR amplification (100%) verified by gel electrophoresis. For S. 
mansoni sensitivity was highest for LAMP amplification (100%) for standard extraction than PCR and LAMP with 
LAMP-PURE (99% and 94%). The LAMP-PURE extraction produced false negatives, which require further 
investigation for this field usable extraction kit. Overall high positive and negative predictive values (90% − 
100%) for both species demonstrated a highly robust approach. The LAMP approach is close to point of care use 
and equally sensitive and specific to detection of species-specific DNA by PCR. LAMP can be an effective means 
to detect low intensity infection due to its simplicity and minimal DNA extraction requirement. This will enhance 
the effectiveness of surveillance and MDA control programs of schistosomiasis. 
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1. Introduction 
Point of care diagnosis is a priority for strategies that rely on mass drug administration (MDA) for the control of 
many of the neglected tropical diseases(NTDs). As these strategies are applied and evaluated it is clear that the 
use of signs such as hematuria for urinary schistosomiasis or examination of stool smears such as the Kato-Katz 
(KK) test are unsatisfactory as diagnostics because of the lack of sensitivity (Lodh et al., 2013). Currently a point 
of care test for Schistosoma mansoni, the circulating cathodic antigen (CCA) test is in use, but it is similar in 
sensitivity as the KK smear in detecting S. mansoni and quite inadequate to detect S. haematobium infection 
(Stothard et al., 2006). Recently, however, it has been shown at least with schistosomes, that fragments 
of somatic DNA from both S. haematobiumand S. mansoni are detectable in urine (Ibironke et al., 2011), and can 
be extracted from filter paper through which a urine specimen was filtered and dried and thus avoids the 
collection and handling of stool specimens (Lodh et al., 2014). Although collecting and examining specimens has 
been greatly improved by filtration of urine in the field, and examination in a central laboratory, there still 
remains the need for thermocycler and electrophoresis equipment for the examination. These procedures can 
be replaced in the field by the loop-mediated isothermal amplification (LAMP) technology (Abbasi et al., 2010). 
Detection of parasite species-specific DNA in urine indicates the presence of the actual parasite even when eggs 
or antigens are not always detectable, and schistosome DNA in urine has been shown to clear from infected 
people by two weeks after praziquantel treatment (Ibironke et al., 2012). In a carefully controlled study from 
Zambia, Lodh et al. (2013) showed that detecting S. mansoni species-specific DNA fragment in the urine 
precipitate, there was a 30% disparity between CCA and PCR test. In China, (Xu et al., 2014) showed a six-fold 
difference between the KK smear (performed nine times per sample) and Schistosoma japonicum specific DNA 
detection from serum. Clearly it is important to add parasite species-specific DNA detection to the diagnostic 
repertoire and keep the technology as close to the point of care as possible (Shiff, 2014). The LAMP procedure 
commonly is made up from supplies obtainable from scientific vendors. It is highly specific as it uses four sets of 
primers to amplify six target regions of the DNA (Notomi et al., 2000). It also amplifies DNA fragments 
independent of the standard thermocycler and electrophoresis and can easily be adapted for clinical trials. The 
procedure depends on extraction and purification of the target DNA. This can be done by use of the 
standard DNA extraction kit (such as,QIAmpDNA Blood mini kit), or by other means of purification. The Eiken 
Chemical Company, Japan have produced a LAMP-PURE (Procedure for Ultra Rapid Extraction) kit, which 
incorporates a proprietary method for DNA extraction and purification in order to improve the sensitivity of the 
amplification process. In this work, we compared PCR amplification of DNA extracted and purified with 
QIAmpDNA Blood Mini kit against LAMP amplification of DNA extracted and purified with QIAmp and LAMP-
PURE to determine whether there was any advantage in diagnostic accuracy from 86 filtered urine specimens 
collected from a community in southern Ghana. The objective of this study was to compare the efficacy of two 
methods of extracting DNA from urine deposit on coarse filter paper (Whatman No 3.) dried after filtration and 
stored at room temperature (Ibironke et al., 2011) and their effect on two different types of amplification. 
2. Materials and methods 
2.1. Study design and population 
The study location and population had been described in detail in previous publication (Lodh et al., 2014). 
Briefly, the study was carried out at Tomefa, a district of the greater Accra region in Ghana. Colleagues of the 
Noguchi Memorial Institute for Medical Research (NMIMR) chose this area because of the presence of both S. 
mansoni and S. haematobium and an ongoing study that focused on intestinal schistosomiasis for NMIMR. Stool 
specimens for S. mansoni were examined using the KK method, but there was no urine examination for S. 
haematobium. For this study, urine samples were collected from 86 participants between 5 and 23 years of age 
specifically for DNA detection. Approval for the diagnostic research was provided by NMIMR (IRB: 043/12-13). 
Written study consent was collected from parents or guardians in case of minors and from individuals in case of 
18 years or older. Participants found infected parasitologically were treated by praziquantel by NMIMR and local 
health centers. 
Urine samples (approximately 40–50 mL) were collected between 10:00 am and 2:00 pm and were evaluated for 
color, pH, and specific gravity and for presence of protein, glucose bilirubin and hematuria with Hemastix (Bayer, 
Elkhart, IN). After physiological assessment, approximately 50 mL whole urine was filtered through Whatman 
No. 3 filter paper (Whatman International, Maidstone, England), then dried under a fly-proof net and 
individually packed in Ziploc bags with desiccant. Filter papers without any personal information and only with 
number associated with specimen along with age, sex, physiological and diagnostic information were brought 
back to Johns Hopkins School of Public Health, Baltimore, Maryland for molecular diagnosis. DNA was extracted 
from urine sediment captured on filter paper by QIAmpDNA Blood Mini Kit (Qiagen, MD) and LAMP PURE kit 
(Eiken Chemical Co., Ltd, Japan). DNA extracted by Qiagen kit was evaluated by both PCR and LAMP. LAMP PURE 
kit extracted DNA was evaluated only by LAMP. 
2.2. DNA extraction from urine by Qiagen and LAMP PURE kit 
Each filter paper was folded to form a cone to drain the urine. DNA was extracted from marked inner quadrant 
at the base of filter paper by QIAmpDNA Blood Mini Kit (Qiagen, MD, USA). From each quadrant 15 pieces of 
∼1 mm diameter paper disc was punched off by a regular paper punch. After every use, the paper punch and 
scissor was cleaned by 10% bleach solution and distilled water to avoid any contamination. All 15 paper discs for 
each sample were placed in 1.5 mL Eppendorf tube with 600 μL nuclease-free water and heated at 95 °C for 
10 min and then kept on a rotor at room temperature (22–25 °C) for 16–18 h. The next day water solution was 
transferred to a Qiagen QIAmp 2 mL column tube and DNA was extracted by following manufacturer’s protocol. 
The adjacent quadrant was used to extract DNA by LAMP-PURE kit. The PURE kit was consisted of a series of 
extraction and purifying steps. Step 1: An aliquot of sample (water extract as described above) was heated at 
90 °C for 10 min using a water bath to lyse any cellular material. This was added to the manufacturers DNA 
extraction solution, mixed by inversion and incubated. Step 2: The sample was then treated 
with adsorbent ingredient to remove inhibitory materials contained in the sample and to neutralize the solution 
without any loss of the target DNA. 
DNA concentration was measured using the NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, 
USA). Qiagen-kit-extracted DNA concentration was ranged from 1 to 10 ng/μL. PURE-kit-extracted DNA 
concentration was ranged from 50 to 1200 ng/μL. Therefore, PURE-kit-extracted DNA was diluted at 1:10 ratio 
as DNA concentration was too high for amplification. 
2.3. PCR amplification for S. mansoni and S. haematobium 
PCR amplification was carried out in 10 μL volume with positive and negative controls. For S. mansoni, KK 
positives were used as positive control and for S. haematobium, hematuria and urine filtration positives were 
used as positive control. Water was used as negative control for both parasite species. For PCR amplification, the 
reaction volume consisted of 5 μL of PCR Master Mix, 2X (Promega, Madison, WI, USA), 0.5 μL (10 μM) of each 
amplification primers, 1.5–2 μL of 25 mM MgCl2, 2 μL of DNA (concentration: 4–6 ng/μL) and rest nuclease-free-
water. The amplification profile for S. mansoni was initial denaturation at 95 °C for 10 min and 35 cycles at 95 °C 
for 30 s, 60 °C for 90 s, 72 °C for 30 s and a final extension at 72 °C for 5 min. For S. haematobium the denaturing 
step was at 95 °C for 10 min, followed by 33 cycles of 95 °C for 30 s, 53 °C for 90 s, and 72 °C for 1 min, followed 
by a final extension step at 60 °C for 5 min. To confirm amplification and correct ampliconsize, PCR products 
were visualized in 2% agarose gel stained with ethidium bromide(10 mg/μL) with 50 bp DNA marker (New 
England BioLabs Inc., Ipswich, MA, USA). 
Eighty-six urine samples were investigated by PCR for both schistosome species DNA obtained from Qiagen 
miniprep. For S. mansoni, PCR was carried out by amplifying 110 bp fragment from a highly repeated 121 bp 
region of S. mansonidescribed by Hamburger (Hamburger et al., 1991). Primers for PCR amplification were 
described by Pontes et al. (Pontes et al., 2002). For S. haematobium 121 bp Dra Irepeat fragment was amplified 
by primers previously designed by Hamburger et al. (Hamburger et al., 2001). In case of both schistosome 
species the repeat fragments comprise of 12–16% of each parasite genome (∼600,000 copies per cell) occur in 
different region of genomes of these two schistosome parasites. 
2.4. LAMP amplification for S. mansoni and S. haematobium 
The LAMP ready-to-use buffer mix was prepared to do the LAMP amplification and was performed on two 
separate DNA templates, one (labeled LAMP) was obtained with Qiagen Miniprep kit and the second (labeled 
LAMP-PURE) was obtained with LAMP-PURE extraction and purification kit. The following procedures were 
carried out. The buffer mix was composed of 2X concentration of the following reagents: 10X LAMP buffer 
(Eiken Chemical Co., Ltd, Japan), 5 M Betaine (Sigma, St. Louis, MO), 10 mM dNTPs (Promega, Madison, WI). 
Four μL of ready mix buffer was used for 10 μL LAMP reaction mix. Other than ready mix the reaction mix 
contained 0.5 μL of LAMP primers (5 pmoles of F3 and B3 and 40 pmoles of FIP and BIP), 1 μL of Bst DNA 
polymerase (Lucigen, Middleton, WI), 2 μL of extracted DNA and 0.5 μL nuclease free water. LAMP amplification 
was for 2 h at 63 °C with inactivation for 5 min at 80 °C. Detection of LAMP products were performed by using 
SYBR Green I stain (Life Technologies, Grand Island, NY) by adding 1 μL (1:20 dilution). To confirm correct 
amplification, LAMP products were visualized in 2% agarose gel stained with ethidium bromide (10 mg/μL) and 
run with 50 bp ladder (New England BioLabs Inc., Ipswich, MA). Details of primers were used, including the 
internal species specific F3 and B3 as well as the loop FIB and BIP primers for each schistosome species were 
given in Table 1. 
Table 1. Primer sets used for species-specific DNA amplification of Schistosoma mansoni and S. haematobium by 







Oligonucleotide sequence Reference 
Schistosoma 
mansoni 
LAMP F3 5′ GAT CTG AAT CCG ACC AAC CG 3′ Hamburger et 
al., 2013   
B3 5′ AAC GCC CAC GCT CTC GCA 3′ 
 
  
FIP 5′ AAA TCC GTC CAG TGG TTT TTT TGA 
AAA TCG TTG TAT CTC CG 3′ 
 
  
BIP 5′ CCG AAA CCA CTG GAC GGA TTT TTA 
TTT TTA ATC TAA AAC AAA CAT C 3′ 
 
 
PCR SmPF 5′ GAT CTG AAT CCG ACC AAC CG 3′ Pontes et al., 
2002   




LAMP F3 5′ GAT CTC ACC TAT CAG ACG 3′ Hamburger et 
al., 2013   
B3 5 5' GTC ACC AAT AAT ATG AAA C 3' 
 
  
FIP 5′ CCA ACA ATT TTA AAT TTT ATC AGA 
CGA AAC AAA GAA AAT 3′ 
 
  
BIP 5′ GGT CGT ATC GTT GTG AAA TTT TCA 
CCA ATA ATA TGA AAC AAT 3' 
 
 
PCR ShDra1F 5′ TCA CAA CGA TAC GAC CAA C 3′ Hamburger et 
al., 2001   
ShDra1R 5′ GAT CTC ACC TAT CAG ACG AAA C 3′ 
 
  
ShDra1R 5′ TCA CAA CGA TAC GAC CAA C 3′ 2001 
a LAMP = loop-mediated isothermal amplification; PCR = polymerase chain reaction; F3 = forward external 
primer; B3 = backwards external primer; FIP = forward internal primer; BIP = backwards internal primer. 
2.5. Statistical analyses 
The analytical procedure was designed to compare two approaches of DNA amplification. Specificity and 
sensitivity of urine-based DNA detection for diagnosis of current schistosome infections had been evaluated 
(Lodh et al., 2014). Data generated in the study were evaluated quantitatively and qualitatively. Also, agreement 
statistics, Bowker’s Symmetry (Anne and Sonja 2007) was calculated to determine the accuracy of the tests. 
Bowker’s symmetry tested for lack of agreement between comparisons of two tests. Only numerical values 
(1 = positive and 0 = negative) were used for statistical analysis. Data for S. mansoni were represented as PCR_S. 
mansoni_QiaAmp kit, LAMP_S. mansoni_ QiaAmp kit, LAMP_S. mansoni_PURE kit, and for S. haematobium were 
represented as PCR_S. haematobium_QiaAmp kit, LAMP_ S. haematobium_QiaAmp kit and LAMP_ S. 
haematobium_PURE kit. 
In this study PCR + was regarded as true positive and PCR − was regarded as true negative. Positivity and 
negativity for LAMP amplification of Qiagen extracted DNA and PURE kit extracted DNA was determined based 
on the PCR outcomes. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) 
was calculated using MedCalc 12.4.0 (MedCalc Software, Belgium). Agreement statistics, Bowker’s Symmetry 
was calculated by JMP 9 (JMP® v9, SAS Institute Inc., Cary, North Carolina) to determine the agreement between 
PCR and LAMP diagnostic tests. 
2.6. Assessment of positive and negative cases 
The results were analyzed as follows: 
• If KK+ then presence of infection confirmed for S. mansoni. 
• If PCR+ or LAMP+ (S. haematobium primers) presence of infection for S. haematobium. 
• If PCR+ or LAMP+ (S. mansoni primers) presence of infection for S. mansoni. 
• If both products were amplified from one specimen then presence of dual S. mansoni and S. 
haematobium infection. 
3. Results 
3.1. Evaluation of PCR and LAMP 
We found a large number of mixed S. mansoni/S.haematobium infections by both PCR and LAMP amplification 
(Table 2). There were 72/86 S. haematobium and 81/86 S. mansoni with LAMP assay, whereas 21% false 
negativity with the KK specimen exam. The LAMP-PURE for S. mansoni did not perform well as expected with 
this parasite, showing 6% false negative. In supplementary material, two by two tables are presented for 
comparison of the PCR and LAMP amplification methods and the two DNA extraction methods. Overall the 
detection of S. haematobium using LAMP method is similar for both extraction and only two specimens were 
missed by PCR amplified from Qiagen extracted DNA. The differences were not significant. 
Table 2. Frequency of infected and uninfected people from Ghana for Schistosoma mansoni and S. 
haematobium evaluated by polymerase chain reaction (PCR) and loop mediated isothermal amplification 
(LAMP), where DNA was extracted by QiaAmp extraction kit and by LAMP-PURE kit. 









KKa_S. mansoni 57 (66%) 0 11 (13%) 18 (21%) 86 
PCR_S. mansoni_QiaAmp kit 74 (86%) 0 11 (13%) 1 (1%) 86 
LAMP_S. mansoni_QiaAmp kit 81 (94%) 0 5 (6%) 0 86 
LAMP_S. mansoni_PURE kit 76 (88%) 0 5 (6%) 5 (6%) 86 
PCR_S. haematobium_QiaAmp 
kit 
70 (81%) 0 16 (19%) 0 86 
LAMP_ S. 
haematobium_QiaAmp kit 
72 (84%) 0 14 (16%) 0 86 
LAMP_ S. haematobium_PURE 
kit 
72 (84%) 0 14 (16%) 0 86 
aKK = Kato-Katz test. 
3.2. Assessment of agreement statistics 
Agreement statistics was calculated by comparing two above-mentioned molecular methods for both S. 
mansoni and S. haematobium. Bowker’s symmetry calculated the level of disagreement between tests in 2-way 
tables and the test decision was based on X2 approximation of the distribution of the test statistic (Anne and 
Sonja, 2007). For S. mansoni, the Bowker Symmetry was significantly different from random (P < 0.05) for the 
comparison between LAMP_QiaAmp and PCR and in case of LAMP_QiaAmp and LAMP_PURE, indicating that 
test positives by LAMP_QiaAmp were highly unlikely to be the same with PCR and LAMP_PURE (Table 3). The 
test agreement was significantly correlated for PCR and LAMP_PURE (0.33; Table 4). For S. haematobium, the 
symmetry of disagreement was also significantly lower throughout for all comparisons (0 and 2), which indicated 
that test positives by LAMP_QiaAmp are highly likely to be same with PCR and LAMP_PURE (Table 3). 
Table 3. Estimation of Bowker symmetry index (Agreement Statistics) for two species-specific DNA 
amplification methods and two DNA extraction methods. 
Diagnostic Test Bowker’s Symmetry test*   
Symmetry of Disagreement P valueψ 
PCR_S. mansoni_QiaAmp kit vs. LAMP_S. mansoni_ QiaAmp kit 7 0.0082* 
PCR_S. mansoni_QiaAmp kit vs LAMP_S. mansoni_PURE kit 0.33 0.5637 
LAMP_S. mansoni_ QiaAmp kit vs. LAMP_S. mansoni_PURE kit 5 0.0253* 
PCR_S. haematobium_QiaAmp kit vs. LAMP_ S. haematobium_QiaAmp kit 2 0.1573 
PCR_S. haematobium_QiaAmp kit vs. LAMP_ S. haematobium_PURE kit 2 0.1573 
LAMP_ S. haematobium_QiaAmp kit vs. LAMP_ S. haematobium_PURE kit 0 1.0000 
*Bowker’s Symmetry test = this test checks for symmetry in 2-way tables and the test decision is based on 
a X2 approximation of the distribution of the test statistic. 
ψ = α level was set at 0.05. 
* = Significant. 
4. Discussion 
In the current study, LAMP was used for integrated diagnosis of single or mixed schistosome infection by 
amplifying parasite species-specific DNA from urine samples. Recently our group successfully detected 
schistosome parasite-specific DNA by PCR amplification in S. haematobium (Ibironke et al., 2011) and S. 
mansoni(Lodh et al., 2013) individually and for both S. haematobium and S. mansoni (Lodh et al., 2014) from 
urine sediment captured on filter paper through filtration. In all cases, our approach showed high sensitivity and 
specificity with no cross-reactivity with other related helminthes. However, there is an added cost and 
technological limitation involved for employing PCR based DNA detection in the field (Hamburger et al., 1991). A 
simple molecular procedure adapted as a point of care diagnostic test to rural conditions is needed, and for this 
we used LAMP technology. 
In Africa the two human species of schistosomes, S. mansoni and S. haematobium are often concurrent in the 
human population (Hotez and Fenwick, 2009). This sympatric distribution also raises the problem of accurate 
and specific diagnosis of asymptomatic cases. It is important to remember that such cases can still infect 
molluscan hosts and keep the transmission going. So these reservoirs of infection must be detected in order to 
eliminate the risk of human re-infection. Sensitivity of microscopic examination decreases in older people so 
that the relationship of each parasite with human morbidity is not evaluated (King and Dangerfield-Cha, 2008) 
and this will affect disease treatment and any control effort (Booth et al., 2004, Ernould et al., 1999). 
Differentiating between these species can be challenging, as it involves the examination of urine for egg or 
antigen by dipstick or by CCA and stool for egg detection. Logistically and technically such tasks are time 
consuming and as shown (Ibironke et al., 2011, Lodh et al., 2013) these procedures are inadequately sensitive 
and produce false negative results. Active schistosome infections are normally diagnosed by demonstrating 
parasite eggs in the excreta, however in chronic and low-intensity infections these eggs appear sporadically and 
are difficult to detect. This is extremely critical with intestinal schistosomiasis when the standard method, the KK 
technique uses only 50mg feces, some 1/10,000 of a normal fecal mass. This is particularly important when mass 
chemotherapy programs are designed to reduce or eliminate foci of infection. For S. haematobium, the repeat 
DNA detection in urine is superior in sensitivity and specificity to antigen capture, hematuria or ELISA detection 
of antibody. WHO has drawn attention to the need for tests with high specificity but also improved sensitivity, 
which can be applicable in the field. We have demonstrated that it is possible to detect DNA specific to both 
schistosome parasites from a single source of urine, thus simplifying the collection and performance of tests that 
are more sensitive and more specific than the standard diagnostic tests (Enk et al., 2010). This will be a 
significant development in schistosome diagnosis, it would greatly increase the ease by which specimen 
collections are made and it will increase the accuracy of the diagnosis significantly as has been shown in our 
work with S. haematobium. 
The success of control strategies requires a simple, easy-to-perform, sensitive and accurate diagnostic test. 
However, current diagnostics of all forms of schistosomiasis are insufficient to detect low-
intensity asymptomatic and chronic infections. Detection of eggs and surface and/or secreted antigens is prone 
to missing low-grade infections (Stothard et al., 2006Krolewiecki et al., 2013), which comprise the majority of 
infections particularly adults with long-standing infections and juveniles who have been treated. As the control 
programs become more and more effective in reducing the parasite burden in the individual, the issue of 
diagnostic sensitivity will become more critical in the assessment of program effectiveness (Ibironke et al., 2011; 
Krolewiecki et al., 2013). That is why an accurate and sensitive point of care diagnostic test is needed. 
LAMP has already been used for several major NTDs, notably for malaria (Hopkins et al., 2013, Polley et al., 
2013), tuberculosis (Mitarai et al., 2011), toxoplasmosis(Mikita et al., 2013), leishmaniasis (Mikita et al., 2014) 
and for schistosome-infected-snails (Hamburger et al., 2013). LAMP is rapid and simple as the reaction can be 
done at a constant temperature with only one type of enzyme (Tomita et al., 2008). LAMP is highly specific as it 
uses four sets of primers to amplify six target regions of the DNA (Tomita et al., 2008). It also amplifies DNA 
fragments independent of the standard thermocycler and electrophoresis and can easily be adapted for clinical 
trials. By using LAMP simpler, rapid and specific schistosome DNA-based testing of urine can be employed in the 
field for rapid detection of human schistosome parasites. We show that isothermal amplification of schistosome 
species-specific DNA is an effective diagnostic procedure and is equal to PCR amplification for both species of 
schistosome. 
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Appendix A. Supplementary data 
The following is Supplementary data to this article:  
  
Supplementary material  
Quantitative analysis of two different diagnostic tests on 86 filtered urine sediments collected in Ghana where 0 = negative and 1 = positive.  
 
A. S. mansoni 
 
                                                                                                                                                                                                              
Count 0 1 Total 
0 5 0 5 
1 7 74 81 
Total 12 74 86 
 
 
B. S. haematobium 













Count 0 1 Total 
0 5 5 10 
1 0 76 76 
Total 5 81 86 
Count 0 1 Total 
0 5 5 10 
1 7 69 76 
Total 12 74 86 
Count 0 1 Total 
0 14 0 14 
1 2 70 72 
Total 16 70 86 
Count 0 1 Total 
0 14 0 14 
1 0 72 72 
Total 14 72 86 
Count 0 1 Total 
0 14 0 14 
1 2 70 72 
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